nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—Sulpiride—Glyburide—type 2 diabetes mellitus	0.44	1	CrCrCtD
Amisulpride—HTR7—Bromocriptine—type 2 diabetes mellitus	0.1	0.295	CbGbCtD
Amisulpride—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0785	0.231	CbGbCtD
Amisulpride—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0725	0.213	CbGbCtD
Amisulpride—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0461	0.136	CbGbCtD
Amisulpride—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0424	0.125	CbGbCtD
Amisulpride—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00449	0.122	CbGeAlD
Amisulpride—HTR2A—arteriole—type 2 diabetes mellitus	0.00439	0.119	CbGeAlD
Amisulpride—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00302	0.0817	CbGeAlD
Amisulpride—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.0028	0.0758	CbGeAlD
Amisulpride—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.00218	0.059	CbGeAlD
Amisulpride—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00188	0.051	CbGeAlD
Amisulpride—HTR2A—hindlimb—type 2 diabetes mellitus	0.00174	0.0471	CbGeAlD
Amisulpride—HTR7—artery—type 2 diabetes mellitus	0.00171	0.0463	CbGeAlD
Amisulpride—HTR7—nerve—type 2 diabetes mellitus	0.0017	0.046	CbGeAlD
Amisulpride—DRD2—nerve—type 2 diabetes mellitus	0.0016	0.0435	CbGeAlD
Amisulpride—HTR7—endothelium—type 2 diabetes mellitus	0.00145	0.0391	CbGeAlD
Amisulpride—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.00136	0.0368	CbGeAlD
Amisulpride—HTR2A—artery—type 2 diabetes mellitus	0.00107	0.0289	CbGeAlD
Amisulpride—HTR2A—nerve—type 2 diabetes mellitus	0.00106	0.0287	CbGeAlD
Amisulpride—HTR2A—endothelium—type 2 diabetes mellitus	0.000901	0.0244	CbGeAlD
Amisulpride—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000694	0.0188	CbGeAlD
Amisulpride—DRD2—retina—type 2 diabetes mellitus	0.000664	0.018	CbGeAlD
Amisulpride—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000662	0.0179	CbGeAlD
Amisulpride—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000612	0.0166	CbGeAlD
Amisulpride—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000594	0.0161	CbGeAlD
Amisulpride—HTR7—kidney—type 2 diabetes mellitus	0.000582	0.0158	CbGeAlD
Amisulpride—HTR2A—retina—type 2 diabetes mellitus	0.000438	0.0119	CbGeAlD
Amisulpride—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000371	0.01	CbGeAlD
Amisulpride—HTR7—liver—type 2 diabetes mellitus	0.000368	0.00996	CbGeAlD
Amisulpride—HTR2A—kidney—type 2 diabetes mellitus	0.000363	0.00983	CbGeAlD
Amisulpride—HTR2A—liver—type 2 diabetes mellitus	0.000229	0.00621	CbGeAlD
Amisulpride—Hypotension—Glyburide—type 2 diabetes mellitus	0.000174	0.00138	CcSEcCtD
Amisulpride—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000174	0.00138	CcSEcCtD
Amisulpride—Nausea—Repaglinide—type 2 diabetes mellitus	0.000174	0.00138	CcSEcCtD
Amisulpride—Asthenia—Glipizide—type 2 diabetes mellitus	0.000174	0.00138	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000173	0.00138	CcSEcCtD
Amisulpride—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000173	0.00138	CcSEcCtD
Amisulpride—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000173	0.00137	CcSEcCtD
Amisulpride—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000172	0.00137	CcSEcCtD
Amisulpride—Angioedema—Valsartan—type 2 diabetes mellitus	0.000172	0.00137	CcSEcCtD
Amisulpride—Malnutrition—Metformin—type 2 diabetes mellitus	0.000171	0.00136	CcSEcCtD
Amisulpride—Pruritus—Glipizide—type 2 diabetes mellitus	0.000171	0.00136	CcSEcCtD
Amisulpride—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000171	0.00136	CcSEcCtD
Amisulpride—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000171	0.00136	CcSEcCtD
Amisulpride—Weight increased—Ramipril—type 2 diabetes mellitus	0.000171	0.00136	CcSEcCtD
Amisulpride—Angioedema—Orlistat—type 2 diabetes mellitus	0.00017	0.00135	CcSEcCtD
Amisulpride—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000169	0.00134	CcSEcCtD
Amisulpride—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000168	0.00133	CcSEcCtD
Amisulpride—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000167	0.00132	CcSEcCtD
Amisulpride—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000166	0.00132	CcSEcCtD
Amisulpride—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000166	0.00132	CcSEcCtD
Amisulpride—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000166	0.00132	CcSEcCtD
Amisulpride—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000166	0.00132	CcSEcCtD
Amisulpride—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000165	0.00131	CcSEcCtD
Amisulpride—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000164	0.00131	CcSEcCtD
Amisulpride—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000164	0.0013	CcSEcCtD
Amisulpride—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000164	0.0013	CcSEcCtD
Amisulpride—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000164	0.0013	CcSEcCtD
Amisulpride—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000162	0.00129	CcSEcCtD
Amisulpride—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000162	0.00129	CcSEcCtD
Amisulpride—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000162	0.00129	CcSEcCtD
Amisulpride—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000162	0.00129	CcSEcCtD
Amisulpride—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000162	0.00129	CcSEcCtD
Amisulpride—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000162	0.00128	CcSEcCtD
Amisulpride—Convulsion—Orlistat—type 2 diabetes mellitus	0.000161	0.00128	CcSEcCtD
Amisulpride—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000161	0.00128	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000161	0.00128	CcSEcCtD
Amisulpride—Tremor—Metformin—type 2 diabetes mellitus	0.000161	0.00128	CcSEcCtD
Amisulpride—Dizziness—Glipizide—type 2 diabetes mellitus	0.00016	0.00127	CcSEcCtD
Amisulpride—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00016	0.00127	CcSEcCtD
Amisulpride—Anxiety—Valsartan—type 2 diabetes mellitus	0.00016	0.00127	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000159	0.00127	CcSEcCtD
Amisulpride—Tension—Irbesartan—type 2 diabetes mellitus	0.000159	0.00126	CcSEcCtD
Amisulpride—Angiopathy—Losartan—type 2 diabetes mellitus	0.000159	0.00126	CcSEcCtD
Amisulpride—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000159	0.00126	CcSEcCtD
Amisulpride—Anxiety—Orlistat—type 2 diabetes mellitus	0.000158	0.00125	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000157	0.00125	CcSEcCtD
Amisulpride—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000157	0.00125	CcSEcCtD
Amisulpride—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000157	0.00125	CcSEcCtD
Amisulpride—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000156	0.00124	CcSEcCtD
Amisulpride—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000156	0.00124	CcSEcCtD
Amisulpride—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000156	0.00124	CcSEcCtD
Amisulpride—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000155	0.00123	CcSEcCtD
Amisulpride—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000155	0.00123	CcSEcCtD
Amisulpride—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000154	0.00122	CcSEcCtD
Amisulpride—Vomiting—Glipizide—type 2 diabetes mellitus	0.000154	0.00122	CcSEcCtD
Amisulpride—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000153	0.00122	CcSEcCtD
Amisulpride—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000152	0.00121	CcSEcCtD
Amisulpride—Headache—Glipizide—type 2 diabetes mellitus	0.000152	0.00121	CcSEcCtD
Amisulpride—Tremor—Irbesartan—type 2 diabetes mellitus	0.000152	0.00121	CcSEcCtD
Amisulpride—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000151	0.0012	CcSEcCtD
Amisulpride—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000151	0.0012	CcSEcCtD
Amisulpride—Tension—Losartan—type 2 diabetes mellitus	0.000149	0.00119	CcSEcCtD
Amisulpride—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000149	0.00119	CcSEcCtD
Amisulpride—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000149	0.00119	CcSEcCtD
Amisulpride—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000149	0.00118	CcSEcCtD
Amisulpride—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000149	0.00118	CcSEcCtD
Amisulpride—Agitation—Irbesartan—type 2 diabetes mellitus	0.000149	0.00118	CcSEcCtD
Amisulpride—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000149	0.00118	CcSEcCtD
Amisulpride—Hypertension—Metformin—type 2 diabetes mellitus	0.000148	0.00118	CcSEcCtD
Amisulpride—Urticaria—Glyburide—type 2 diabetes mellitus	0.000148	0.00118	CcSEcCtD
Amisulpride—Nervousness—Losartan—type 2 diabetes mellitus	0.000148	0.00118	CcSEcCtD
Amisulpride—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000148	0.00118	CcSEcCtD
Amisulpride—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000147	0.00117	CcSEcCtD
Amisulpride—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000147	0.00117	CcSEcCtD
Amisulpride—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000147	0.00117	CcSEcCtD
Amisulpride—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000147	0.00117	CcSEcCtD
Amisulpride—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000146	0.00116	CcSEcCtD
Amisulpride—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000146	0.00116	CcSEcCtD
Amisulpride—Headache—Pioglitazone—type 2 diabetes mellitus	0.000145	0.00115	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000145	0.00115	CcSEcCtD
Amisulpride—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000145	0.00115	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000144	0.00115	CcSEcCtD
Amisulpride—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000144	0.00115	CcSEcCtD
Amisulpride—Nausea—Glipizide—type 2 diabetes mellitus	0.000144	0.00114	CcSEcCtD
Amisulpride—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000144	0.00114	CcSEcCtD
Amisulpride—Hypotension—Valsartan—type 2 diabetes mellitus	0.000144	0.00114	CcSEcCtD
Amisulpride—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000143	0.00114	CcSEcCtD
Amisulpride—Constipation—Gliclazide—type 2 diabetes mellitus	0.000143	0.00114	CcSEcCtD
Amisulpride—Tremor—Losartan—type 2 diabetes mellitus	0.000143	0.00113	CcSEcCtD
Amisulpride—Headache—Glimepiride—type 2 diabetes mellitus	0.000141	0.00112	CcSEcCtD
Amisulpride—Headache—Sitagliptin—type 2 diabetes mellitus	0.000141	0.00112	CcSEcCtD
Amisulpride—Agitation—Losartan—type 2 diabetes mellitus	0.00014	0.00111	CcSEcCtD
Amisulpride—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00014	0.00111	CcSEcCtD
Amisulpride—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000139	0.00111	CcSEcCtD
Amisulpride—Angioedema—Losartan—type 2 diabetes mellitus	0.000139	0.00111	CcSEcCtD
Amisulpride—Insomnia—Valsartan—type 2 diabetes mellitus	0.000139	0.00111	CcSEcCtD
Amisulpride—Insomnia—Orlistat—type 2 diabetes mellitus	0.000137	0.00109	CcSEcCtD
Amisulpride—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000137	0.00109	CcSEcCtD
Amisulpride—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000137	0.00109	CcSEcCtD
Amisulpride—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000137	0.00109	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000137	0.00109	CcSEcCtD
Amisulpride—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000137	0.00109	CcSEcCtD
Amisulpride—Somnolence—Valsartan—type 2 diabetes mellitus	0.000137	0.00109	CcSEcCtD
Amisulpride—Leukopenia—Losartan—type 2 diabetes mellitus	0.000136	0.00108	CcSEcCtD
Amisulpride—Skin disorder—Metformin—type 2 diabetes mellitus	0.000136	0.00108	CcSEcCtD
Amisulpride—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000135	0.00108	CcSEcCtD
Amisulpride—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000135	0.00108	CcSEcCtD
Amisulpride—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000135	0.00108	CcSEcCtD
Amisulpride—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000135	0.00107	CcSEcCtD
Amisulpride—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000135	0.00107	CcSEcCtD
Amisulpride—Nausea—Glimepiride—type 2 diabetes mellitus	0.000134	0.00107	CcSEcCtD
Amisulpride—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000134	0.00106	CcSEcCtD
Amisulpride—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000134	0.00106	CcSEcCtD
Amisulpride—Asthenia—Glyburide—type 2 diabetes mellitus	0.000134	0.00106	CcSEcCtD
Amisulpride—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000133	0.00106	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000133	0.00105	CcSEcCtD
Amisulpride—Fatigue—Valsartan—type 2 diabetes mellitus	0.000132	0.00105	CcSEcCtD
Amisulpride—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000132	0.00105	CcSEcCtD
Amisulpride—Pruritus—Glyburide—type 2 diabetes mellitus	0.000132	0.00105	CcSEcCtD
Amisulpride—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000131	0.00104	CcSEcCtD
Amisulpride—Constipation—Valsartan—type 2 diabetes mellitus	0.000131	0.00104	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000131	0.00104	CcSEcCtD
Amisulpride—Fatigue—Orlistat—type 2 diabetes mellitus	0.000131	0.00104	CcSEcCtD
Amisulpride—Hypotension—Metformin—type 2 diabetes mellitus	0.000131	0.00104	CcSEcCtD
Amisulpride—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000131	0.00104	CcSEcCtD
Amisulpride—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00013	0.00103	CcSEcCtD
Amisulpride—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000129	0.00103	CcSEcCtD
Amisulpride—Anxiety—Losartan—type 2 diabetes mellitus	0.000129	0.00103	CcSEcCtD
Amisulpride—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000128	0.00102	CcSEcCtD
Amisulpride—Tension—Ramipril—type 2 diabetes mellitus	0.000128	0.00102	CcSEcCtD
Amisulpride—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000128	0.00102	CcSEcCtD
Amisulpride—Headache—Bromocriptine—type 2 diabetes mellitus	0.000128	0.00101	CcSEcCtD
Amisulpride—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000127	0.00101	CcSEcCtD
Amisulpride—Nervousness—Ramipril—type 2 diabetes mellitus	0.000127	0.00101	CcSEcCtD
Amisulpride—Dry mouth—Losartan—type 2 diabetes mellitus	0.000127	0.00101	CcSEcCtD
Amisulpride—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000126	0.000999	CcSEcCtD
Amisulpride—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000126	0.000998	CcSEcCtD
Amisulpride—Somnolence—Metformin—type 2 diabetes mellitus	0.000124	0.000989	CcSEcCtD
Amisulpride—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000124	0.000987	CcSEcCtD
Amisulpride—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000123	0.000981	CcSEcCtD
Amisulpride—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000123	0.00098	CcSEcCtD
Amisulpride—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000123	0.000979	CcSEcCtD
Amisulpride—Tremor—Ramipril—type 2 diabetes mellitus	0.000122	0.000973	CcSEcCtD
Amisulpride—Urticaria—Valsartan—type 2 diabetes mellitus	0.000122	0.000971	CcSEcCtD
Amisulpride—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000122	0.000969	CcSEcCtD
Amisulpride—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000121	0.000966	CcSEcCtD
Amisulpride—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000121	0.000962	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000121	0.000961	CcSEcCtD
Amisulpride—Fatigue—Metformin—type 2 diabetes mellitus	0.000121	0.000959	CcSEcCtD
Amisulpride—Urticaria—Orlistat—type 2 diabetes mellitus	0.000121	0.000959	CcSEcCtD
Amisulpride—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00012	0.000955	CcSEcCtD
Amisulpride—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00012	0.000954	CcSEcCtD
Amisulpride—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00012	0.000954	CcSEcCtD
Amisulpride—Agitation—Ramipril—type 2 diabetes mellitus	0.00012	0.000954	CcSEcCtD
Amisulpride—Constipation—Metformin—type 2 diabetes mellitus	0.00012	0.000951	CcSEcCtD
Amisulpride—Angioedema—Ramipril—type 2 diabetes mellitus	0.000119	0.000949	CcSEcCtD
Amisulpride—Vomiting—Glyburide—type 2 diabetes mellitus	0.000118	0.000942	CcSEcCtD
Amisulpride—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000118	0.000941	CcSEcCtD
Amisulpride—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000117	0.000933	CcSEcCtD
Amisulpride—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000117	0.000929	CcSEcCtD
Amisulpride—Headache—Glyburide—type 2 diabetes mellitus	0.000117	0.000928	CcSEcCtD
Amisulpride—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000116	0.000924	CcSEcCtD
Amisulpride—Hypotension—Losartan—type 2 diabetes mellitus	0.000116	0.000923	CcSEcCtD
Amisulpride—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000114	0.00091	CcSEcCtD
Amisulpride—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000114	0.00091	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000114	0.000906	CcSEcCtD
Amisulpride—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000114	0.000905	CcSEcCtD
Amisulpride—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000113	0.0009	CcSEcCtD
Amisulpride—Convulsion—Ramipril—type 2 diabetes mellitus	0.000113	0.000899	CcSEcCtD
Amisulpride—Constipation—Irbesartan—type 2 diabetes mellitus	0.000113	0.000898	CcSEcCtD
Amisulpride—Insomnia—Losartan—type 2 diabetes mellitus	0.000112	0.000894	CcSEcCtD
Amisulpride—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000112	0.000889	CcSEcCtD
Amisulpride—Urticaria—Metformin—type 2 diabetes mellitus	0.000111	0.000884	CcSEcCtD
Amisulpride—Anxiety—Ramipril—type 2 diabetes mellitus	0.000111	0.000881	CcSEcCtD
Amisulpride—Nausea—Glyburide—type 2 diabetes mellitus	0.000111	0.00088	CcSEcCtD
Amisulpride—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000111	0.00088	CcSEcCtD
Amisulpride—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000111	0.000879	CcSEcCtD
Amisulpride—Somnolence—Losartan—type 2 diabetes mellitus	0.00011	0.000878	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00011	0.000878	CcSEcCtD
Amisulpride—Asthenia—Valsartan—type 2 diabetes mellitus	0.00011	0.000877	CcSEcCtD
Amisulpride—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000109	0.00087	CcSEcCtD
Amisulpride—Asthenia—Orlistat—type 2 diabetes mellitus	0.000109	0.000866	CcSEcCtD
Amisulpride—Pruritus—Valsartan—type 2 diabetes mellitus	0.000109	0.000864	CcSEcCtD
Amisulpride—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000109	0.000864	CcSEcCtD
Amisulpride—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000108	0.000859	CcSEcCtD
Amisulpride—Pruritus—Orlistat—type 2 diabetes mellitus	0.000107	0.000854	CcSEcCtD
Amisulpride—Fatigue—Losartan—type 2 diabetes mellitus	0.000107	0.000852	CcSEcCtD
Amisulpride—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000106	0.000846	CcSEcCtD
Amisulpride—Constipation—Losartan—type 2 diabetes mellitus	0.000106	0.000845	CcSEcCtD
Amisulpride—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000105	0.000836	CcSEcCtD
Amisulpride—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000105	0.000834	CcSEcCtD
Amisulpride—Headache—Gliclazide—type 2 diabetes mellitus	0.000105	0.000833	CcSEcCtD
Amisulpride—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000104	0.000831	CcSEcCtD
Amisulpride—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000104	0.00083	CcSEcCtD
Amisulpride—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000104	0.000826	CcSEcCtD
Amisulpride—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000103	0.000823	CcSEcCtD
Amisulpride—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000103	0.000819	CcSEcCtD
Amisulpride—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000102	0.000808	CcSEcCtD
Amisulpride—Dizziness—Valsartan—type 2 diabetes mellitus	0.000102	0.000808	CcSEcCtD
Amisulpride—Dizziness—Orlistat—type 2 diabetes mellitus	0.0001	0.000798	CcSEcCtD
Amisulpride—Asthenia—Metformin—type 2 diabetes mellitus	0.0001	0.000798	CcSEcCtD
Amisulpride—Hypotension—Ramipril—type 2 diabetes mellitus	9.96e-05	0.000792	CcSEcCtD
Amisulpride—Nausea—Gliclazide—type 2 diabetes mellitus	9.93e-05	0.00079	CcSEcCtD
Amisulpride—Pruritus—Metformin—type 2 diabetes mellitus	9.9e-05	0.000787	CcSEcCtD
Amisulpride—Urticaria—Losartan—type 2 diabetes mellitus	9.87e-05	0.000785	CcSEcCtD
Amisulpride—Abdominal pain—Losartan—type 2 diabetes mellitus	9.82e-05	0.000781	CcSEcCtD
Amisulpride—Vomiting—Valsartan—type 2 diabetes mellitus	9.77e-05	0.000777	CcSEcCtD
Amisulpride—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.73e-05	0.000774	CcSEcCtD
Amisulpride—Vomiting—Orlistat—type 2 diabetes mellitus	9.65e-05	0.000768	CcSEcCtD
Amisulpride—Insomnia—Ramipril—type 2 diabetes mellitus	9.64e-05	0.000766	CcSEcCtD
Amisulpride—Headache—Valsartan—type 2 diabetes mellitus	9.62e-05	0.000765	CcSEcCtD
Amisulpride—Diarrhoea—Metformin—type 2 diabetes mellitus	9.57e-05	0.000761	CcSEcCtD
Amisulpride—Headache—Orlistat—type 2 diabetes mellitus	9.51e-05	0.000756	CcSEcCtD
Amisulpride—Asthenia—Irbesartan—type 2 diabetes mellitus	9.47e-05	0.000753	CcSEcCtD
Amisulpride—Somnolence—Ramipril—type 2 diabetes mellitus	9.47e-05	0.000753	CcSEcCtD
Amisulpride—Dyspepsia—Ramipril—type 2 diabetes mellitus	9.38e-05	0.000746	CcSEcCtD
Amisulpride—Pruritus—Irbesartan—type 2 diabetes mellitus	9.34e-05	0.000743	CcSEcCtD
Amisulpride—Dizziness—Metformin—type 2 diabetes mellitus	9.25e-05	0.000736	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	9.2e-05	0.000731	CcSEcCtD
Amisulpride—Fatigue—Ramipril—type 2 diabetes mellitus	9.19e-05	0.00073	CcSEcCtD
Amisulpride—Hypersensitivity—Losartan—type 2 diabetes mellitus	9.15e-05	0.000728	CcSEcCtD
Amisulpride—Nausea—Valsartan—type 2 diabetes mellitus	9.13e-05	0.000726	CcSEcCtD
Amisulpride—Constipation—Ramipril—type 2 diabetes mellitus	9.11e-05	0.000725	CcSEcCtD
Amisulpride—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9.03e-05	0.000718	CcSEcCtD
Amisulpride—Nausea—Orlistat—type 2 diabetes mellitus	9.02e-05	0.000717	CcSEcCtD
Amisulpride—Asthenia—Losartan—type 2 diabetes mellitus	8.92e-05	0.000709	CcSEcCtD
Amisulpride—Vomiting—Metformin—type 2 diabetes mellitus	8.9e-05	0.000707	CcSEcCtD
Amisulpride—Pruritus—Losartan—type 2 diabetes mellitus	8.79e-05	0.000699	CcSEcCtD
Amisulpride—Headache—Metformin—type 2 diabetes mellitus	8.76e-05	0.000697	CcSEcCtD
Amisulpride—Dizziness—Irbesartan—type 2 diabetes mellitus	8.73e-05	0.000694	CcSEcCtD
Amisulpride—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.71e-05	0.000693	CcSEcCtD
Amisulpride—Diarrhoea—Losartan—type 2 diabetes mellitus	8.5e-05	0.000676	CcSEcCtD
Amisulpride—Urticaria—Ramipril—type 2 diabetes mellitus	8.46e-05	0.000673	CcSEcCtD
Amisulpride—Abdominal pain—Ramipril—type 2 diabetes mellitus	8.42e-05	0.00067	CcSEcCtD
Amisulpride—Vomiting—Irbesartan—type 2 diabetes mellitus	8.39e-05	0.000668	CcSEcCtD
Amisulpride—Nausea—Metformin—type 2 diabetes mellitus	8.31e-05	0.000661	CcSEcCtD
Amisulpride—Headache—Irbesartan—type 2 diabetes mellitus	8.27e-05	0.000658	CcSEcCtD
Amisulpride—Dizziness—Losartan—type 2 diabetes mellitus	8.22e-05	0.000653	CcSEcCtD
Amisulpride—Vomiting—Losartan—type 2 diabetes mellitus	7.9e-05	0.000628	CcSEcCtD
Amisulpride—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000624	CcSEcCtD
Amisulpride—Nausea—Irbesartan—type 2 diabetes mellitus	7.84e-05	0.000624	CcSEcCtD
Amisulpride—Headache—Losartan—type 2 diabetes mellitus	7.78e-05	0.000619	CcSEcCtD
Amisulpride—Asthenia—Ramipril—type 2 diabetes mellitus	7.64e-05	0.000608	CcSEcCtD
Amisulpride—Pruritus—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000599	CcSEcCtD
Amisulpride—Nausea—Losartan—type 2 diabetes mellitus	7.38e-05	0.000587	CcSEcCtD
Amisulpride—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.29e-05	0.00058	CcSEcCtD
Amisulpride—Dizziness—Ramipril—type 2 diabetes mellitus	7.05e-05	0.00056	CcSEcCtD
Amisulpride—Vomiting—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000539	CcSEcCtD
Amisulpride—Headache—Ramipril—type 2 diabetes mellitus	6.67e-05	0.000531	CcSEcCtD
Amisulpride—Nausea—Ramipril—type 2 diabetes mellitus	6.33e-05	0.000503	CcSEcCtD
Amisulpride—HTR2B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.41e-06	0.000162	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	9.39e-06	0.000162	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	9.29e-06	0.00016	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APOB—type 2 diabetes mellitus	9.27e-06	0.00016	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	9.26e-06	0.00016	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	9.26e-06	0.00016	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.23e-06	0.000159	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	9.14e-06	0.000158	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	9.13e-06	0.000158	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AGT—type 2 diabetes mellitus	9.13e-06	0.000158	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.12e-06	0.000157	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	9.12e-06	0.000157	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	9.12e-06	0.000157	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.09e-06	0.000157	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—GNB3—type 2 diabetes mellitus	9.05e-06	0.000156	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	9.01e-06	0.000156	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AGT—type 2 diabetes mellitus	8.98e-06	0.000155	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	8.98e-06	0.000155	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CYBA—type 2 diabetes mellitus	8.97e-06	0.000155	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.93e-06	0.000154	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.93e-06	0.000154	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AVP—type 2 diabetes mellitus	8.93e-06	0.000154	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.89e-06	0.000153	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	8.87e-06	0.000153	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—LPL—type 2 diabetes mellitus	8.85e-06	0.000153	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.85e-06	0.000153	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	8.83e-06	0.000152	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CYBA—type 2 diabetes mellitus	8.83e-06	0.000152	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	8.82e-06	0.000152	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.78e-06	0.000152	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.78e-06	0.000152	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.76e-06	0.000151	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—C3—type 2 diabetes mellitus	8.72e-06	0.000151	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	8.68e-06	0.00015	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.68e-06	0.00015	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.67e-06	0.00015	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.64e-06	0.000149	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.64e-06	0.000149	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APOB—type 2 diabetes mellitus	8.63e-06	0.000149	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.59e-06	0.000148	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.54e-06	0.000147	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.49e-06	0.000147	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.43e-06	0.000146	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.32e-06	0.000144	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.31e-06	0.000143	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.3e-06	0.000143	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.3e-06	0.000143	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AGT—type 2 diabetes mellitus	8.29e-06	0.000143	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—LPL—type 2 diabetes mellitus	8.24e-06	0.000142	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.17e-06	0.000141	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.16e-06	0.000141	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.15e-06	0.000141	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8.13e-06	0.00014	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—APOE—type 2 diabetes mellitus	8.12e-06	0.00014	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—LEP—type 2 diabetes mellitus	8.12e-06	0.00014	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.06e-06	0.000139	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.04e-06	0.000139	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GCG—type 2 diabetes mellitus	8.03e-06	0.000139	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.03e-06	0.000139	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.03e-06	0.000139	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8e-06	0.000138	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—C3—type 2 diabetes mellitus	7.97e-06	0.000138	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GCG—type 2 diabetes mellitus	7.9e-06	0.000136	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.9e-06	0.000136	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.9e-06	0.000136	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.88e-06	0.000136	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.78e-06	0.000134	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.75e-06	0.000134	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.73e-06	0.000133	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.66e-06	0.000132	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.6e-06	0.000131	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.59e-06	0.000131	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.58e-06	0.000131	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AGT—type 2 diabetes mellitus	7.57e-06	0.000131	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.52e-06	0.00013	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.45e-06	0.000129	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—LEP—type 2 diabetes mellitus	7.42e-06	0.000128	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APOE—type 2 diabetes mellitus	7.42e-06	0.000128	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—C3—type 2 diabetes mellitus	7.42e-06	0.000128	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.4e-06	0.000128	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.39e-06	0.000127	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.38e-06	0.000127	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.34e-06	0.000127	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.27e-06	0.000125	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.26e-06	0.000125	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.24e-06	0.000125	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.07e-06	0.000122	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.06e-06	0.000122	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AGT—type 2 diabetes mellitus	7.05e-06	0.000122	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7e-06	0.000121	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.99e-06	0.000121	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—INS—type 2 diabetes mellitus	6.94e-06	0.00012	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.93e-06	0.00012	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.92e-06	0.000119	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APOE—type 2 diabetes mellitus	6.9e-06	0.000119	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—LEP—type 2 diabetes mellitus	6.9e-06	0.000119	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.88e-06	0.000119	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AVP—type 2 diabetes mellitus	6.83e-06	0.000118	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.83e-06	0.000118	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.83e-06	0.000118	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.83e-06	0.000118	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.81e-06	0.000118	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.8e-06	0.000117	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.77e-06	0.000117	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AVP—type 2 diabetes mellitus	6.72e-06	0.000116	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.72e-06	0.000116	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.71e-06	0.000116	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.71e-06	0.000116	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.7e-06	0.000116	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.69e-06	0.000115	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.68e-06	0.000115	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.66e-06	0.000115	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.62e-06	0.000114	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOB—type 2 diabetes mellitus	6.6e-06	0.000114	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.59e-06	0.000114	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.57e-06	0.000113	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.51e-06	0.000112	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.5e-06	0.000112	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOB—type 2 diabetes mellitus	6.5e-06	0.000112	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.47e-06	0.000112	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.39e-06	0.00011	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.37e-06	0.00011	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—INS—type 2 diabetes mellitus	6.34e-06	0.000109	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LPL—type 2 diabetes mellitus	6.3e-06	0.000109	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.24e-06	0.000108	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LPL—type 2 diabetes mellitus	6.2e-06	0.000107	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.17e-06	0.000106	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.16e-06	0.000106	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.13e-06	0.000106	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.13e-06	0.000106	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.1e-06	0.000105	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.08e-06	0.000105	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.08e-06	0.000105	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.07e-06	0.000105	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.91e-06	0.000102	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—INS—type 2 diabetes mellitus	5.9e-06	0.000102	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.82e-06	0.0001	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.82e-06	0.0001	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.81e-06	0.0001	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.8e-06	0.0001	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—RELA—type 2 diabetes mellitus	5.73e-06	9.88e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.71e-06	9.86e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.71e-06	9.85e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.7e-06	9.84e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.68e-06	9.8e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	5.68e-06	9.79e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—C3—type 2 diabetes mellitus	5.58e-06	9.64e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.56e-06	9.59e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.56e-06	9.59e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.42e-06	9.35e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.41e-06	9.34e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.4e-06	9.32e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	5.39e-06	9.31e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.33e-06	9.19e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.31e-06	9.17e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AGT—type 2 diabetes mellitus	5.31e-06	9.16e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.3e-06	9.15e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	5.28e-06	9.12e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	5.28e-06	9.12e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—RELA—type 2 diabetes mellitus	5.23e-06	9.03e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.22e-06	9.01e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.22e-06	9e-05	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.21e-06	9e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	5.2e-06	8.97e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	5.2e-06	8.97e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.17e-06	8.93e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.17e-06	8.93e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.16e-06	8.91e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.14e-06	8.87e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.13e-06	8.85e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.98e-06	8.6e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.9e-06	8.46e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.88e-06	8.42e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—RELA—type 2 diabetes mellitus	4.87e-06	8.4e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.83e-06	8.33e-05	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.76e-06	8.22e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.73e-06	8.17e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.72e-06	8.14e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.71e-06	8.13e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.69e-06	8.09e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.64e-06	8e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	4.51e-06	7.79e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SRC—type 2 diabetes mellitus	4.5e-06	7.77e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.46e-06	7.7e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	4.44e-06	7.66e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.44e-06	7.66e-05	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.43e-06	7.65e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.41e-06	7.61e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.39e-06	7.58e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.38e-06	7.56e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.37e-06	7.54e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.37e-06	7.53e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.36e-06	7.53e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.36e-06	7.53e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.34e-06	7.5e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.33e-06	7.46e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.3e-06	7.41e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.29e-06	7.41e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.27e-06	7.38e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.15e-06	7.16e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.15e-06	7.15e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	4.11e-06	7.1e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.11e-06	7.09e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.08e-06	7.04e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.03e-06	6.95e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.02e-06	6.94e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.01e-06	6.91e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.96e-06	6.83e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.96e-06	6.83e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.94e-06	6.81e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.89e-06	6.72e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.89e-06	6.72e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	3.83e-06	6.6e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.73e-06	6.43e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.73e-06	6.43e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.68e-06	6.34e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	3.67e-06	6.33e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.6e-06	6.22e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.42e-06	5.9e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.39e-06	5.85e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.36e-06	5.8e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.35e-06	5.79e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.34e-06	5.76e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.34e-06	5.76e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.31e-06	5.71e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.29e-06	5.67e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.18e-06	5.48e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.14e-06	5.42e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.12e-06	5.39e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.09e-06	5.33e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.08e-06	5.32e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	3.03e-06	5.23e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.03e-06	5.23e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.93e-06	5.05e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.88e-06	4.97e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.85e-06	4.92e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.81e-06	4.84e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.8e-06	4.83e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.77e-06	4.78e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.62e-06	4.52e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.58e-06	4.45e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.58e-06	4.44e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.57e-06	4.43e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.56e-06	4.41e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.53e-06	4.36e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.38e-06	4.1e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.97e-06	3.4e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.94e-06	3.35e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.82e-06	3.14e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.79e-06	3.09e-05	CbGpPWpGaD
